APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Diagnosis & Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HIV Diagnosis & Treatment Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchHIV Diagnosis & Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Diagnosis & Treatment Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal HIV Diagnosis & Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Diagnosis & Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Diagnosis & Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global HIV Diagnosis & Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for HIV Diagnosis & Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HIV Diagnosis & Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HIV Diagnosis & Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HIV Diagnosis & Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of HIV Diagnosis & Treatment include Abbott Laboratories, Johnson & Johnson, GlaxoSmithKline, Gilead, F. Hoffmann-La Roche, Cipla, Bristol-Myers Squibb and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for HIV Diagnosis & Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HIV Diagnosis & Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for HIV Diagnosis & Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HIV Diagnosis & Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HIV Diagnosis & Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for HIV Diagnosis & Treatment revenue, projected growth trends, production technology, application and end-user industry.

HIV Diagnosis & Treatment Segment by Company

Abbott Laboratories

Johnson & Johnson

GlaxoSmithKline

Gilead

F. Hoffmann-La Roche

Cipla

Bristol-Myers Squibb

Boehringer Ingelheim

HIV Diagnosis & Treatment Segment by Type

Saliva Tests

ELISA Test

Western Blot

Viral Load Test

Others

HIV Diagnosis & Treatment Segment by Application

Hospitals

Clinics

HIV Diagnosis & Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Diagnosis & Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Diagnosis & Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Diagnosis & Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of HIV Diagnosis & Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of HIV Diagnosis & Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Diagnosis & Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Saliva Tests Major Player Table 3. ELISA Test Major Player Table 4. Western Blot Major Player Table 5. Viral Load Test Major Player Table 6. Others Major Player Table 7. Global HIV Diagnosis & Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Player Table 9. Clinics Major Player Table 10. HIV Diagnosis & Treatment Industry Trends Table 11. HIV Diagnosis & Treatment Industry Drivers Table 12. HIV Diagnosis & Treatment Industry Opportunities and Challenges Table 13. HIV Diagnosis & Treatment Industry Restraints Table 14. Global HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global HIV Diagnosis & Treatment Market Size by Region (2021-2026) & (US$ Million) Table 16. Global HIV Diagnosis & Treatment Market Share by Region (2021-2026) Table 17. Global HIV Diagnosis & Treatment Market Size by Region (2027-2032) & (US$ Million) Table 18. Global HIV Diagnosis & Treatment Market Share by Region (2027-2032) Table 19. Global HIV Diagnosis & Treatment Revenue by Players (US$ Million) & (2021-2026) Table 20. Global HIV Diagnosis & Treatment Revenue Market Share by Players (2021-2026) Table 21. Global HIV Diagnosis & Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global HIV Diagnosis & Treatment Key Players Headquarters & Area Served Table 23. Global HIV Diagnosis & Treatment Players, Product Type & Application Table 24. Global HIV Diagnosis & Treatment Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global HIV Diagnosis & Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global HIV Diagnosis & Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global HIV Diagnosis & Treatment Revenue by Type (2021-2026) & (US$ Million) Table 29. Global HIV Diagnosis & Treatment Revenue by Type (2027-2032) & (US$ Million) Table 30. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2021-2026) Table 31. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2027-2032) Table 32. Global HIV Diagnosis & Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global HIV Diagnosis & Treatment Revenue by Application (2021-2026) & (US$ Million) Table 34. Global HIV Diagnosis & Treatment Revenue by Application (2027-2032) & (US$ Million) Table 35. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2021-2026) Table 36. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2027-2032) Table 37. Abbott Laboratories Company Information Table 38. Abbott Laboratories Business Overview Table 39. Abbott Laboratories HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Abbott Laboratories HIV Diagnosis & Treatment Product Portfolio Table 41. Abbott Laboratories Recent Development Table 42. Johnson & Johnson Company Information Table 43. Johnson & Johnson Business Overview Table 44. Johnson & Johnson HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Johnson & Johnson HIV Diagnosis & Treatment Product Portfolio Table 46. Johnson & Johnson Recent Development Table 47. GlaxoSmithKline Company Information Table 48. GlaxoSmithKline Business Overview Table 49. GlaxoSmithKline HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GlaxoSmithKline HIV Diagnosis & Treatment Product Portfolio Table 51. GlaxoSmithKline Recent Development Table 52. Gilead Company Information Table 53. Gilead Business Overview Table 54. Gilead HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Gilead HIV Diagnosis & Treatment Product Portfolio Table 56. Gilead Recent Development Table 57. F. Hoffmann-La Roche Company Information Table 58. F. Hoffmann-La Roche Business Overview Table 59. F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Portfolio Table 61. F. Hoffmann-La Roche Recent Development Table 62. Cipla Company Information Table 63. Cipla Business Overview Table 64. Cipla HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Cipla HIV Diagnosis & Treatment Product Portfolio Table 66. Cipla Recent Development Table 67. Bristol-Myers Squibb Company Information Table 68. Bristol-Myers Squibb Business Overview Table 69. Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bristol-Myers Squibb HIV Diagnosis & Treatment Product Portfolio Table 71. Bristol-Myers Squibb Recent Development Table 72. Boehringer Ingelheim Company Information Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Boehringer Ingelheim HIV Diagnosis & Treatment Product Portfolio Table 76. Boehringer Ingelheim Recent Development Table 77. North America HIV Diagnosis & Treatment Revenue by Type (2021-2026) & (US$ Million) Table 78. North America HIV Diagnosis & Treatment Revenue by Type (2027-2032) & (US$ Million) Table 79. North America HIV Diagnosis & Treatment Revenue by Application (2021-2026) & (US$ Million) Table 80. North America HIV Diagnosis & Treatment Revenue by Application (2027-2032) & (US$ Million) Table 81. North America HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America HIV Diagnosis & Treatment Revenue by Country (2021-2026) & (US$ Million) Table 83. North America HIV Diagnosis & Treatment Revenue by Country (US$ Million) & (2027-2032) Table 84. Europe HIV Diagnosis & Treatment Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe HIV Diagnosis & Treatment Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe HIV Diagnosis & Treatment Revenue by Application (2021-2026) & (US$ Million) Table 87. Europe HIV Diagnosis & Treatment Revenue by Application (2027-2032) & (US$ Million) Table 88. Europe HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe HIV Diagnosis & Treatment Revenue by Country (2021-2026) & (US$ Million) Table 90. Europe HIV Diagnosis & Treatment Revenue by Country (US$ Million) & (2027-2032) Table 91. China HIV Diagnosis & Treatment Revenue by Type (2021-2026) & (US$ Million) Table 92. China HIV Diagnosis & Treatment Revenue by Type (2027-2032) & (US$ Million) Table 93. China HIV Diagnosis & Treatment Revenue by Application (2021-2026) & (US$ Million) Table 94. China HIV Diagnosis & Treatment Revenue by Application (2027-2032) & (US$ Million) Table 95. Asia HIV Diagnosis & Treatment Revenue by Type (2021-2026) & (US$ Million) Table 96. Asia HIV Diagnosis & Treatment Revenue by Type (2027-2032) & (US$ Million) Table 97. Asia HIV Diagnosis & Treatment Revenue by Application (2021-2026) & (US$ Million) Table 98. Asia HIV Diagnosis & Treatment Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia HIV Diagnosis & Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia HIV Diagnosis & Treatment Revenue by Region (US$ Million) & (2021-2026) Table 101. Asia HIV Diagnosis & Treatment Revenue by Region (US$ Million) & (2027-2032) Table 102. SAMEA HIV Diagnosis & Treatment Revenue by Type (2021-2026) & (US$ Million) Table 103. SAMEA HIV Diagnosis & Treatment Revenue by Type (2027-2032) & (US$ Million) Table 104. SAMEA HIV Diagnosis & Treatment Revenue by Application (2021-2026) & (US$ Million) Table 105. SAMEA HIV Diagnosis & Treatment Revenue by Application (2027-2032) & (US$ Million) Table 106. SAMEA HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. SAMEA HIV Diagnosis & Treatment Revenue by Country (2021-2026) & (US$ Million) Table 108. SAMEA HIV Diagnosis & Treatment Revenue by Country (US$ Million) & (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. HIV Diagnosis & Treatment Image Figure 2. Global HIV Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV Diagnosis & Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Saliva Tests Image Figure 5. ELISA Test Image Figure 6. Western Blot Image Figure 7. Viral Load Test Image Figure 8. Others Image Figure 9. Global HIV Diagnosis & Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global HIV Diagnosis & Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Global HIV Diagnosis & Treatment Market Size (US$ Million) & (2021-2032) Figure 14. Global HIV Diagnosis & Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global HIV Diagnosis & Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global HIV Diagnosis & Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global HIV Diagnosis & Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global HIV Diagnosis & Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global HIV Diagnosis & Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America HIV Diagnosis & Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America HIV Diagnosis & Treatment Revenue Share by Type (2021-2032) Figure 26. North America HIV Diagnosis & Treatment Revenue Share by Application (2021-2032) Figure 27. North America HIV Diagnosis & Treatment Revenue Share by Country (2021-2032) Figure 28. United States HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe HIV Diagnosis & Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe HIV Diagnosis & Treatment Revenue Share by Type (2021-2032) Figure 33. Europe HIV Diagnosis & Treatment Revenue Share by Application (2021-2032) Figure 34. Europe HIV Diagnosis & Treatment Revenue Share by Country (2021-2032) Figure 35. Germany HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China HIV Diagnosis & Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China HIV Diagnosis & Treatment Revenue Share by Type (2021-2032) Figure 45. China HIV Diagnosis & Treatment Revenue Share by Application (2021-2032) Figure 46. Asia HIV Diagnosis & Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia HIV Diagnosis & Treatment Revenue Share by Type (2021-2032) Figure 48. Asia HIV Diagnosis & Treatment Revenue Share by Application (2021-2032) Figure 49. Asia HIV Diagnosis & Treatment Revenue Share by Region (2021-2032) Figure 50. Japan HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA HIV Diagnosis & Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA HIV Diagnosis & Treatment Revenue Share by Type (2021-2032) Figure 58. SAMEA HIV Diagnosis & Treatment Revenue Share by Application (2021-2032) Figure 59. SAMEA HIV Diagnosis & Treatment Revenue Share by Country (2021-2032) Figure 60. Brazil HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt HIV Diagnosis & Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Saliva Tests
  • ELISA Test
  • Western Blot
  • Viral Load Test
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Abbott Laboratories
  • Johnson & Johnson
  • GlaxoSmithKline
  • Gilead
  • F. Hoffmann-La Roche
  • Cipla
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HIV Diagnosis & Treatment Market by Type
  3. 1.2.1 Global HIV Diagnosis & Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Saliva Tests
  5. 1.2.3 ELISA Test
  6. 1.2.4 Western Blot
  7. 1.2.5 Viral Load Test
  8. 1.2.6 Others
  9. 1.3 HIV Diagnosis & Treatment Market by Application
  10. 1.3.1 Global HIV Diagnosis & Treatment Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 HIV Diagnosis & Treatment Market Dynamics
  1. 2.1 HIV Diagnosis & Treatment Industry Trends
  2. 2.2 HIV Diagnosis & Treatment Industry Drivers
  3. 2.3 HIV Diagnosis & Treatment Industry Opportunities and Challenges
  4. 2.4 HIV Diagnosis & Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global HIV Diagnosis & Treatment Market Perspective (2021-2032)
  2. 3.2 Global HIV Diagnosis & Treatment Growth Trends by Region
  3. 3.2.1 Global HIV Diagnosis & Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HIV Diagnosis & Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global HIV Diagnosis & Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global HIV Diagnosis & Treatment Revenue by Players
  2. 4.1.1 Global HIV Diagnosis & Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global HIV Diagnosis & Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global HIV Diagnosis & Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HIV Diagnosis & Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global HIV Diagnosis & Treatment Key Players Headquarters & Area Served
  7. 4.4 Global HIV Diagnosis & Treatment Players, Product Type & Application
  8. 4.5 Global HIV Diagnosis & Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global HIV Diagnosis & Treatment Market CR5 and HHI
  11. 4.6.3 2025 HIV Diagnosis & Treatment Tier 1, Tier 2, and Tier 3
5 HIV Diagnosis & Treatment Market Size by Type
  1. 5.1 Global HIV Diagnosis & Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global HIV Diagnosis & Treatment Revenue by Type (2021-2032)
  3. 5.3 Global HIV Diagnosis & Treatment Revenue Market Share by Type (2021-2032)
6 HIV Diagnosis & Treatment Market Size by Application
  1. 6.1 Global HIV Diagnosis & Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global HIV Diagnosis & Treatment Revenue by Application (2021-2032)
  3. 6.3 Global HIV Diagnosis & Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories HIV Diagnosis & Treatment Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson HIV Diagnosis & Treatment Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline HIV Diagnosis & Treatment Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 Gilead
  20. 7.4.1 Gilead Company Information
  21. 7.4.2 Gilead Business Overview
  22. 7.4.3 Gilead HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Gilead HIV Diagnosis & Treatment Product Portfolio
  24. 7.4.5 Gilead Recent Developments
  25. 7.5 F. Hoffmann-La Roche
  26. 7.5.1 F. Hoffmann-La Roche Company Information
  27. 7.5.2 F. Hoffmann-La Roche Business Overview
  28. 7.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Portfolio
  30. 7.5.5 F. Hoffmann-La Roche Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cipla HIV Diagnosis & Treatment Product Portfolio
  36. 7.6.5 Cipla Recent Developments
  37. 7.7 Bristol-Myers Squibb
  38. 7.7.1 Bristol-Myers Squibb Company Information
  39. 7.7.2 Bristol-Myers Squibb Business Overview
  40. 7.7.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bristol-Myers Squibb HIV Diagnosis & Treatment Product Portfolio
  42. 7.7.5 Bristol-Myers Squibb Recent Developments
  43. 7.8 Boehringer Ingelheim
  44. 7.8.1 Boehringer Ingelheim Company Information
  45. 7.8.2 Boehringer Ingelheim Business Overview
  46. 7.8.3 Boehringer Ingelheim HIV Diagnosis & Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boehringer Ingelheim HIV Diagnosis & Treatment Product Portfolio
  48. 7.8.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America HIV Diagnosis & Treatment Revenue (2021-2032)
  2. 8.2 North America HIV Diagnosis & Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America HIV Diagnosis & Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America HIV Diagnosis & Treatment Revenue by Type (2027-2032)
  5. 8.3 North America HIV Diagnosis & Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America HIV Diagnosis & Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America HIV Diagnosis & Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America HIV Diagnosis & Treatment Revenue by Application (2027-2032)
  9. 8.5 North America HIV Diagnosis & Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America HIV Diagnosis & Treatment Revenue by Country
  11. 8.6.1 North America HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America HIV Diagnosis & Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America HIV Diagnosis & Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe HIV Diagnosis & Treatment Revenue (2021-2032)
  2. 9.2 Europe HIV Diagnosis & Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe HIV Diagnosis & Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe HIV Diagnosis & Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe HIV Diagnosis & Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe HIV Diagnosis & Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe HIV Diagnosis & Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe HIV Diagnosis & Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe HIV Diagnosis & Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe HIV Diagnosis & Treatment Revenue by Country
  11. 9.6.1 Europe HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe HIV Diagnosis & Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe HIV Diagnosis & Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China HIV Diagnosis & Treatment Revenue (2021-2032)
  2. 10.2 China HIV Diagnosis & Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China HIV Diagnosis & Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China HIV Diagnosis & Treatment Revenue by Type (2027-2032)
  5. 10.3 China HIV Diagnosis & Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China HIV Diagnosis & Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China HIV Diagnosis & Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China HIV Diagnosis & Treatment Revenue by Application (2027-2032)
  9. 10.5 China HIV Diagnosis & Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HIV Diagnosis & Treatment Revenue (2021-2032)
  2. 11.2 Asia HIV Diagnosis & Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia HIV Diagnosis & Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia HIV Diagnosis & Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia HIV Diagnosis & Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia HIV Diagnosis & Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia HIV Diagnosis & Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia HIV Diagnosis & Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia HIV Diagnosis & Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia HIV Diagnosis & Treatment Revenue by Country
  11. 11.6.1 Asia HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia HIV Diagnosis & Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia HIV Diagnosis & Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HIV Diagnosis & Treatment Revenue (2021-2032)
  2. 12.2 SAMEA HIV Diagnosis & Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA HIV Diagnosis & Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA HIV Diagnosis & Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA HIV Diagnosis & Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA HIV Diagnosis & Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA HIV Diagnosis & Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA HIV Diagnosis & Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA HIV Diagnosis & Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA HIV Diagnosis & Treatment Revenue by Country
  11. 12.6.1 SAMEA HIV Diagnosis & Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA HIV Diagnosis & Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA HIV Diagnosis & Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst